These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9486817)

  • 1. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.
    Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H
    J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly specific and sensitive detection of malignancy in urine samples from patients with urothelial cancer by CD44v8-10/CD44v10 competitive RT-PCR.
    Miyake H; Okamoto I; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S; Saya H
    Int J Cancer; 1998 Dec; 79(6):560-4. PubMed ID: 9842962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of malignant cells in pleural fluid or ascites by CD44v8-10/CD44v10 competitive RT-PCR.
    Ahn MJ; Noh YH; Yoon HJ; Yang SC; Sohn JW; Choi JH; Lee YY; Choi IY; Kim IS; Lee YS; Park CK
    Korean J Intern Med; 2001 Mar; 16(1):30-5. PubMed ID: 11417302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Competitive Reverse Transcription-Polymerase Chain Reaction Analysis of Specific CD44 Variant RNA for Detecting Upper Urinary Tract Transitional-Cell Carcinoma.
    Miyake H; Hara I; Arakawa S; Kamidono S
    Mol Urol; 1999; 3(4):365-370. PubMed ID: 10851297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary cytology and competitive reverse transcriptase-polymerase chain reaction analysis of a specific CD44 variant to detect and monitor bladder cancer.
    Miyake H; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S
    J Urol; 1998 Dec; 160(6 Pt 1):2004-8. PubMed ID: 9817310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
    Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
    J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
    Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of CD44 splice variants in malignant and benign pleural effusions.
    Tojo N; Inase N; Ichioka M; Miyazato I; Nara N
    Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene.
    Yoshida K; Sugino T; Bolodeoku J; Warren BF; Goodison S; Woodman A; Toge T; Tahara E; Tarin D
    J Clin Pathol; 1996 Apr; 49(4):300-5. PubMed ID: 8655705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of CD44 variant isoform in urine samples of urothelial cancer patient].
    Hara I; Miyake H; Gohji K; Arakawa S; Kamidono S
    Hinyokika Kiyo; 1999 Aug; 45(8):589-92. PubMed ID: 10500968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
    Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
    Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer.
    Yamao T; Matsumura Y; Shimada Y; Moriya Y; Sugihara K; Akasu T; Fujita S; Kakizoe T
    Gastroenterology; 1998 Jun; 114(6):1196-205. PubMed ID: 9609756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.
    Woodman AC; Sugiyama M; Yoshida K; Sugino T; Borgya A; Goodison S; Matsumura Y; Tarin D
    Am J Pathol; 1996 Nov; 149(5):1519-30. PubMed ID: 8909242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
    Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
    Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
    Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
    PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
    Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
    Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
    Yu Q; Toole BP
    J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PCR-based method for the analysis of human CD44 splice products.
    van Weering DH; Baas PD; Bos JL
    PCR Methods Appl; 1993 Oct; 3(2):100-6. PubMed ID: 7505677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative exon-specific PCR method for the analysis of human CD44 isoform expression.
    Lockhart MS; Gravisaco MJ; Mongini C; Waldner C; Alvarez E; Hajos SE
    Oncol Rep; 1999; 6(1):219-24. PubMed ID: 9864432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.